Download - Biologic PPT

Transcript
Page 1: Biologic PPT

The Biologic Foundations of Psychiatric Nursing

Chapter 8

Page 2: Biologic PPT

Biological Basis of Behavior

• Most human behaviors have a biological basis.

• Symptom expression = behavioral symptoms = brain dysfunction

Page 3: Biologic PPT

Foundation of Biological Basis of Behavior

• Animal modeling– Resembles humans in structure, function

or genetics– Can induce disorders– Usually rats, mice

• Genetics– Populations genetics– Risk factors

Page 4: Biologic PPT

Risk Factors

• Increased risk for developing a disorder

• May be genetic, biological, psychologic or social

Page 5: Biologic PPT

Current Approaches to Studying Neuroanatomy and Neurophysiology

• Comparative

– compared with other life forms

• Developmental

– changes in nervous system throughout the life span

• Cytoarchitectonic

– distribution and arrangement of cells within various parts of brain

• Chemoarchitecture

– identification of neurotransmitters or chemicals

• Functional

– localization of functioning

Page 6: Biologic PPT

Plasticity

• Ability of the brain to change

• Compensates for loss of function in specific area

• Nerve signals may be rerouted.

• Cells learn a new function.

• Nerve tissues may be regenerated.

Page 7: Biologic PPT

Structural Neuroimaging

• Allows for visualization of the brain• Commonly used techniques

– Computed tomography (CT)• X-rays and computers• Iodinated contrast materials administered IV

– Magnetic resonance imaging (MRI)• Place patient in long tube with magnets• Can reconstruct three-dimensional structures• More costly and complicated than CT

Page 8: Biologic PPT

Functional Neuroimaging

• Measurement of physiologic activities

• Two primary imaging procedures (Both require administration of radioactive materials.)– Positron emission tomography (PET)– Single photon emission computed

tomography (SPECT)– Patient can perform functions during this time.

Page 9: Biologic PPT

Neuroanatomy of the CNS

• Cerebrum• Left and right hemispheres• Lobes of the brain

– Frontal– Parietal– Temporal– Occipital– Association Cortex

Page 10: Biologic PPT

Neuroanatomy Subcortical Structures

• Basal ganglia

• Limbic system

• Hippocampus

• Thalamus

• Hypothalamus

• Amygdala

• Limbic midbrain nuclei

Page 11: Biologic PPT

NeuroanatomyOther Important CNS Structures

• Extrapyramidal system

• Pineal body

• Locus ceruleus

• Cerbebellum

Page 12: Biologic PPT

Autonomic Nervous System(Fig. 8.7)

• Neurons of ANS– Efferent or motor system nerves (nerves

moving away from CNS)– Afferent or sensory (nerves moving toward

CNS)

• Sympathetic

• Parasympathetic

Page 13: Biologic PPT

Neurons and Nerve Impulses(Fig. 8.8)

• Soma – cell body– nucleus– ribosomes– endoplasmic reticulum– Golgi apparatus– vesicles– lysomes– mitrochodria

• Axons – conducts impulses• Dendrites – receives impulses

Page 14: Biologic PPT

Synaptic Transmission

• Neurotransmitters - Small molecules directly or indirectly responsible for opening or closing ion channels

• Neuromodulators - Chemical messengers that make the cell membrane more or less susceptible to effects of primary neurotransmitter

• Influx of CA++ into the neuron stimulates release of neurotransmitters into synapse.

• Receptors - Proteins for specific neurotransmitter, “lock and key”

Page 15: Biologic PPT

Fate of Neurotransmitter After Action

• Removed by natural diffusion

• Reuptake into presynaptic terminal

Page 16: Biologic PPT

Receptors

• Sensitivity can change, developing either a greater or lesser response to the neurotransmitter.

• Receptor subtypes– Each major neurotransmitter has several different

subtypes for the chemical, allowing for different effects on the brain.

– Each major neurotransmitter has several different subtypes (e.g., Dopamine, D1, D2, etc.).

Page 17: Biologic PPT

Neurotransmitter Criteria

• Synthesized inside the neuron• Present in the presynaptic terminal• Released into the synaptic cleft, causing a

particular effect on the postsynaptic receptors• An exogenous form of the chemical is

administered as a drug causes identical action.• Chemical is removed from the synaptic cleft by

a specific mechanism.

Page 18: Biologic PPT

Neurotransmitters

• Excitatory – causes activity to occur

• Inhibitory – causes activity to decrease

Page 19: Biologic PPT

Cholinergic Neurotransmitter Acetylcholine (ACh)

• Primary neurotransmitter of parasympathetic nervous system

• Part of sympathetic system • Excitatory neurotransmitter• Follow diffuse projections throughout

the cerebral cortex and limbic system• ACh involved in higher intellectual

functioning and memory

Page 20: Biologic PPT

Cholinergic Receptor

• Muscarinic receptors– Many psychiatric medications block the

muscarinic receptors (anticholinergic).– Blocking the effects causes common side

effects, including:• dry mouth, blurred vision constipation, urinary

retention, and tachycardia

• Nicotinic receptors

Page 21: Biologic PPT

Biogenic Amines

• Synthesized from tyrosine– Dopamine– Norepinephrine– Epinephrine

• Synthesized from tryptophan– Serotonin

• Synthesized from histidine– Histamine

Page 22: Biologic PPT

Neurotransmitters• Acetylcholine

– High intellectual functioning

• Dopamine – Mesocortical and Mesolimbic

• Cognition, memory, emotion, auditory reception

– Nigrostriatal• Influences extrapyramidal system• Subserve voluntary movement• Allows involuntary movement

– Tuberoinfundibular• Endocrine functions

Page 23: Biologic PPT

Dopamine (DA)

• Excitatory neurotransmitter• Involved in cognition, motor and

neuroendocrine functions• Decreased in Parkinson’s, increased in

schizophrenia• Pathways (Figure 8.11)

– Mesocortical, mesolimbic– Nigrostriatal– Tuberoinfundibular

Page 24: Biologic PPT

Dopamine Receptors

• Five subtypes

• D1 and D5 - cortex, hippocampus and amygadala

• D2 found in nigrostriatal system

• D4 found mainly in cortex

Page 25: Biologic PPT

Norepinephrine

• Widely distributed in the peripheral nervous system• Excitatory neurotransmitters play a major role in

mood states.• Decreased NE associated with depression, increased

NE associated with mania• Pathways are named “noradrenergic” and are less

delineated than dopamine pathways.• Pathways in locus cereulus so involve in sleep, wake

Page 26: Biologic PPT

Neurotransmitters• Norepinephrine (Fig. 8.12)

– Sympathetic nervous system functions– Sleep, wakefulness– Reinforce learning

• Serotonin (5-HT) (Fig. 8.13)– Sleep, wakefulness– Control of food intake, hormone secretion, sexual

behavior, mood and emotion, thermoregulation

Page 27: Biologic PPT

Serotonin (5-HT)

• Excitatory neuron distributed within the cerebral cortex, limbic system, an basal ganglia, hypothalamus and cerebellum.

• Involved in regulation of emotion, cognition, sensory perceptions, sleep and appetite.

• Involved in control of food intake, hormone secretin, sexual behavior, thermoregulation and cardiovascular regulation

• Numerous subtypes of receptors

Page 28: Biologic PPT

Histamine

• Recently identified as a neurotransmitter• Originates in hypothalamus and projects

to all major structures in cerebrum, brain and spinal cord

• Functions not well known• Blocking produces side effects, such as

sedation, weight gain and hypotension.

Page 29: Biologic PPT

Aminobutyric Acid (GABA)

• Inhibitory transmitter

• Pathways almost exclusive in CNS, hypothalamus, hippocampus, basal ganglia, spinal cord and cerebellum

• Receptors:– GABAA– GABAB

Page 30: Biologic PPT

Neurotransmitters• Histamine

– Autonomic and neuroendocrine regulation– Blocking – causing sedation and weight gain

• GABA– Control of neuronal excitement– Inhibitory

• Glutamate– Excitatory

• Neuropeptides

Page 31: Biologic PPT

New Fields of Study

• Psychoendocrinology

• Psychoimmunology

• Chronobiology

• Diagnostic Approaches

Page 32: Biologic PPT

Neurophysiologic Procedures

• Electroencephalography (EEG)

• Polysomnography

• Others


Top Related